So, does low-molecular-weight heaprin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?

被引：11

作者：

Warkentin, Theodore E.

Greinacher, Andreas

机构：

[1] Emory Clin, Thorac Surg Sect, Atlanta, GA 30324 USA

[2] Drexel Univ, Coll Med, Intervent Chest & Diagnost Procedures Network SC, Div Pulm Crit Care & Sleep Med, Philadelphia, PA 19104 USA

来源：

CHEST | 2007年 / 132卷 / 04期

关键词：

D O I：

10.1378/chest.07-1553

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1108 / 1110

页数：3

共 15 条

[1] Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. [J].

Breddin, HK ;

Hach-Wunderle, V ;

Nakov, R ;

Kakkar, VV .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09) :626-631

[2] Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism [J].

Creekmore, Freddy M. ;

Oderda, Gary M. ;

Pendleton, Robert C. ;

Brixner, Diana I. .

PHARMACOTHERAPY, 2006, 26 (10) :1438-1445

[3] Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia [J].

Greinacher, A ;

Eichler, P ;

Lietz, T ;

Warkentin, TE .

BLOOD, 2005, 106 (08) :2921-2922

[4] Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies [J].

Greinacher, Andreas ;

Gopinadhan, Manesh ;

Gunther, Jens-Uwe ;

Omer-Adam, Mahmoud A. ;

Strobel, Ulrike ;

Warkentin, Theodore E. ;

Papastavrou, Georg ;

Weitschies, Werner ;

Helm, Christiane A. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) :2386-2393

[5] Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia [J].

Gruel, Y ;

Pouplard, C ;

Nguyen, P ;

Borg, JY ;

Derlon, A ;

Juhan-Vague, I ;

Regnault, V ;

Samama, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :786-792

[6] Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin [J].

Lindhoff-Last, E ;

Nakov, R ;

Misselwitz, F ;

Breddin, HK ;

Bauersachs, R .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :1137-1142

[7] Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis [J].

Martel, N ;

Lee, J ;

Wells, PS .

BLOOD, 2005, 106 (08) :2710-2715

[8] No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin - A metaanalysis [J].

Morris, Timothy A. ;

Castrejon, Selene ;

Devendra, Gehan ;

Gamst, Anthony C. .

CHEST, 2007, 132 (04) :1131-1139

[9] Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies [J].

Pouplard, C ;

May, MA ;

Regina, S ;

Marchand, M ;

Fusciardi, J ;

Gruel, Y .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) :837-841

[10] Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications [J].

Rauova, L ;

Zhai, L ;

Kowalska, MA ;

Arepally, GM ;

Cines, DB ;

Poncz, M .

BLOOD, 2006, 107 (06) :2346-2353

← 1 2 →